Pausing Enhanced Pandemic Pathogen Research Act of 2021
Legislative Progress
Introduced
September 17, 2021
Latest Action
September 20, 2021
Primary Sponsor
Earl L. "Buddy" CarterRepublican(GA)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
59pct
3d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
Pausing Enhanced Pandemic Pathogen Research Act of 2021 This bill temporarily prohibits the National Institutes of Health from conducting or supporting research on any influenza virus or coronavirus if the research is reasonably expected to increase the virus's pathogenicity or transmissibility in mammals via the respiratory route.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2022 · fourth_quarter · Government Issues
H.R.591-Defund EcoHealth Alliance Act- Cutting funding for EcoHealth Alliance H.R.3256 - Defund the Wuhan Institute of Virology Act- Cutting funding for the Wuhan Institute of Virology Act H.R.834- Pandemics Require Evaluating, Planning, And Responding Effectively (PREPARE) Act- Launching commission to study COVID origins, including Wuhan Institute of Virology lab leak hypothesis H.R.1937 - Cost Openness and Spending Transparency (COST) Act- Increasing transparency about federal spending S.760 - Cost Openness and Spending Transparency (COST) Act- Increasing transparency about federal spending S.1260 - United States Innovation and Competition Act of 2021- Funding and oversight of taxpayer-funded animal experiments S.2056 - Stop the Outlay of Payments Act- Cutting funding for grantees that violate federal law H.R.5270 - Pausing Enhanced Pandemic Pathogen Research Act of 2021- Prohibits certain gain-of-function research for 5 years S.3012 - Viral Gain of Function Research Moratorium Act- Prohibits certain gain-of-function research S.3159 - Fairness and Accountability in Underwriting Chinese Institutions Act- Prohibits certain gain-of-function research S.5056 - Defund EcoHealth Alliance Act
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $20,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Government Issues
H.R.591-Defund EcoHealth Alliance Act- Cutting funding for EcoHealth Alliance H.R.3256 - Defund the Wuhan Institute of Virology Act- Cutting funding for the Wuhan Institute of Virology Act H.R.834- Pandemics Require Evaluating, Planning, And Responding Effectively (PREPARE) Act- Launching commission to study COVID origins, including Wuhan Institute of Virology lab leak hypothesis H.R.1937 - Cost Openness and Spending Transparency (COST) Act- Increasing transparency about federal spending S.760 - Cost Openness and Spending Transparency (COST) Act- Increasing transparency about federal spending S.1260 - United States Innovation and Competition Act of 2021- Funding and oversight of taxpayer-funded animal experiments S.2056 - Stop the Outlay of Payments Act- Cutting funding for grantees that violate federal law H.R.5270 - Pausing Enhanced Pandemic Pathogen Research Act of 2021- Prohibits certain gain-of-function research for 5 years S.3012 - Viral Gain of Function Research Moratorium Act- Prohibits certain gain-of-function research S.3159 - Fairness and Accountability in Underwriting Chinese Institutions Act- Prohibits certain gain-of-function research
Client expense: $20,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Government Issues
H.R.591-Defund EcoHealth Alliance Act- Cutting funding for EcoHealth Alliance H.R.3256 - Defund the Wuhan Institute of Virology Act- Cutting funding for the Wuhan Institute of Virology Act H.R.834- Pandemics Require Evaluating, Planning, And Responding Effectively (PREPARE) Act- Launching commission to study COVID origins, including Wuhan Institute of Virology lab leak hypothesis H.R.1937 - Cost Openness and Spending Transparency (COST) Act- Increasing transparency about federal spending S.760 - Cost Openness and Spending Transparency (COST) Act- Increasing transparency about federal spending S.1260 - United States Innovation and Competition Act of 2021- Funding and oversight of taxpayer-funded animal experiments S.2056 - Stop the Outlay of Payments Act- Cutting funding for grantees that violate federal law H.R.5270 - Pausing Enhanced Pandemic Pathogen Research Act of 2021- Prohibits certain gain-of-function research for 5 years
Client expense: $10,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Government Issues
H.R.591-Defund EcoHealth Alliance Act- Cutting funding for EcoHealth Alliance H.R.3256 - Defund the Wuhan Institute of Virology Act- Cutting funding for the Wuhan Institute of Virology Act H.R.834- Pandemics Require Evaluating, Planning, And Responding Effectively (PREPARE) Act- Launching commission to study COVID origins, including Wuhan Institute of Virology lab leak hypothesis H.R.1937 - Cost Openness and Spending Transparency (COST) Act- Increasing transparency about federal spending S.760 - Cost Openness and Spending Transparency (COST) Act- Increasing transparency about federal spending S.1169 - Strategic Competition Act of 2021- Investigating COVID origins, including Wuhan Institute of Virology lab leak hypothesis S.1260 - United States Innovation and Competition Act of 2021- Funding and oversight of taxpayer-funded animal experiments S.2056 - Stop the Outlay of Payments Act- Cutting funding for grantees that violate federal law H.R.5270 - Pausing Enhanced Pandemic Pathogen Research Act of 2021- Prohibits certain gain-of-function research for 5 years
Client expense: $10,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Government Issues
H.R.591-Defund EcoHealth Alliance Act- Cutting funding for EcoHealth Alliance H.R.3256 - Defund the Wuhan Institute of Virology Act- Cutting funding for the Wuhan Institute of Virology Act H.R.834- Pandemics Require Evaluating, Planning, And Responding Effectively (PREPARE) Act- Launching commission to study COVID origins, including Wuhan Institute of Virology lab leak hypothesis H.R.1937 - Cost Openness and Spending Transparency (COST) Act- Increasing transparency about federal spending S.760 - Cost Openness and Spending Transparency (COST) Act- Increasing transparency about federal spending S.1169 - Strategic Competition Act of 2021- Investigating COVID origins, including Wuhan Institute of Virology lab leak hypothesis S.1260 - United States Innovation and Competition Act of 2021- Funding and oversight of taxpayer-funded animal experiments S.2056 - Stop the Outlay of Payments Act H.R.5270 - Pausing Enhanced Pandemic Pathogen Research Act of 2021
Client expense: $10,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Government Issues
H.R.591-Defund EcoHealth Alliance Act- Cutting funding for EcoHealth Alliance H.R.3256 - Defund the Wuhan Institute of Virology Act- Cutting funding for the Wuhan Institute of Virology Act H.R.834- Pandemics Require Evaluating, Planning, And Responding Effectively (PREPARE) Act- Launching commission to study COVID origins, including Wuhan Institute of Virology lab leak hypothesis H.R.1937 - Cost Openness and Spending Transparency (COST) Act- Increasing transparency about federal spending S.760 - Cost Openness and Spending Transparency (COST) Act- Increasing transparency about federal spending S.1169 - Strategic Competition Act of 2021- Investigating COVID origins, including Wuhan Institute of Virology lab leak hypothesis S.1260 - United States Innovation and Competition Act of 2021- Funding and oversight of taxpayer-funded animal experiments S.2056 - Stop the Outlay of Payments Act H.R.5270 - Pausing Enhanced Pandemic Pathogen Research Act of 2021
Client expense: $10,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE